Answers are grounded in this paper and cite their sources.
Basic fibroblast growth factor (bFGF) is a growth factor with proangiogenetic properties. Elevated bone marrow (BM) and peripheral serum bFGF levels have been reported in patients with multiple myeloma (MM)[1][1]-[3][2]; however, the source of bFGF in patients with MM is not completely elucidated.
No takes yet. Share an insight, caveat, or question.
Colla et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: